Australia's Atomo Diagnostics rises on licensing agreement for Syphilis test

Atomo Diagnostics

24/03/2025 03:17

** Shares of Atomo Diagnostics AT1.AX fall 11.8% to A$0.019, their biggest intraday pct jump since mid-August

** The medical device firm hits highest level since March 14

** Co signs an exclusive licensing agreement with the Burnet Institute for their novel rapid Syphilis test

** Says license gives co exclusive rights to commercialise the test

 (Reporting by John Biju in Bengaluru)

 ((John.Biju@thomsonreuters.com;))